Albert Reese - Oct 12, 2022 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Albert Reese Jr./
Stock symbol
LEXX
Transactions as of
Oct 12, 2022
Transactions value $
$0
Form type
4
Date filed
10/13/2022, 05:25 PM
Previous filing
May 25, 2022
Next filing
Jul 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 10.9K Oct 12, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +3.2K +47.06% $0.00 10K Oct 12, 2022 Common Shares 3.2K $1.96 Direct
holding LEXX Stock Options 3.4K Oct 12, 2022 Common Shares 3.4K $4.80 Direct
holding LEXX Stock Options 6.8K Oct 12, 2022 Common Shares 3.4K $3.39 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.